Olive AI's $4B automation bet: $900M raised, units sold off, gone by 2023

Olive was founded in Columbus, Ohio in 2012 by Sean Lane to automate the administrative side of healthcare: prior authorization, claims and utilization management — the paperwork insurers and hospitals most want gone. It sold an 'AI workforce' of software agents that, in its telling, would let payers and providers run revenue-cycle operations with far fewer humans. The pitch was timed perfectly: by 2021, health systems were desperate to cut administrative cost.

The boom was enormous. Olive raised more than $900 million, hit a $4 billion valuation by mid-2021, and claimed deployment at more than 900 hospitals across 40 U.S. states, including over 20 of the top 100 health systems. But growth infrastructure (offices, hiring, an arcade) consumed capital faster than payer contracts converted. 2022 brought rounds of layoffs and retreats from earlier promises, and 2023 turned into a staged fire sale: Availity bought utilization management in April, BurstIQ bought business intelligence in June.

On October 31, 2023, Olive announced it was shutting down after selling its last businesses — clearinghouse and patient access to Waystar, prior authorization to Humata Health. Axios broke the news that morning. A company once valued at $4 billion ended with no entity left, its pieces absorbed by four buyers that simply continued serving the underlying customers.